News

The phase III pacific trial is a randomized, double-blinded, placebo-controlled, multi-center trial of Imfinzi in patients with unresectable Stage III NSCLC whose disease has not progressed following platinum-based chemotherapy concurrent with

Zessly is approved for use in all indications of the reference medicine including rheumatoid arthritis, adult Crohn's disease, pediatric Crohn's disease, adult ulcerative colitis, pediatric ulcerative colitis, ankylosing spondylitis,

Built on the heritage of the market-leading Zetasizer Nano range, and already the proud recipients of a Red Dot 2018 design award, these new flagship instruments deliver significant

According to the drug regulator, patients with PKU suffer from an inability to break down phenylalanine (Phe) since their birth. Palynziq has been developed to reduce blood phenylalanine

The CRL is consistent with the preliminary feedback Cosmo announced on May 9, 2018, stating that the FDA identified unspecified deficiencies that preclude the continuation of the discussion

The company received series A funding under the round led by Oxford Sciences Innovation (OSI), and the participants include Neptune, RT Ventures, GT Healthcare, Tanarra, Fushia and personal

The deal is expected to fetch about $520m to the US-based Cara Therapeutics. The licensing of Korsuva, an anti-itching and anti-pain injection, with VFMCRP will be only for

The shareholding is to be acquired in an all-cash, combined Stock Purchase Agreement by Takeda’s joint venture partner in Techpool: Shanghai Pharmaceutical Holding Co. Ltd. (Shanghai Pharma SSE

The investigational oral treatment would be used in addition to insulin therapy to improve blood sugar control in adults with type 1 diabetes. Sanofi development global head and